Alzheimer's Disease is characterized by the presence of both amyloid plaques and neurofibrillary tangles in cortex. Increasing evidence favors the deposition of amyloid beta protein (Abeta) in plaques as an early and possibly primary event in the pathogenesis of AD, a process that may be related to altered expression or processing of the amyloid precursor protein (APP).To date, the mechanisms that underlie the formation and subsequent deposition of Abeta in brain are unknown. The recent discovery of a constitutive pathway that releases Abeta into media of cultured cells has provided a unique opportunity to understand the mechanism of Abeta formation because of a cleavage within the Abeta domain. Alternatively, APP may be internalized from the cell surface without secretion and directed into the endocytic pathway and ultimately to lysosomes. Results from our preliminary studies suggest that Abeta is generated from endocytosed cell surface APP molecules. These observations lead to the first hypothesis in this proposal: APP that is appropriately targeted to the cell surface and then internalized is the precursors of Abeta released into media. This hypothesis will be examined by two specific aims: 1. localization of the proteolytic steps which generate Abeta and secreted APP in transfected mammalian cells, and 2. characterization of the internalization pathway of APP by morphological and biochemical approaches using normal and mutant APP molecules. Although mutations in the APP gene identified in a few cases of familial AD have provided the strongest link between APP, amyloidogenesis, and the pathogenesis of AD, how these mutations result in disease or altered cellular metabolism is unknown. Building on the first hypothesis, we suggest in the second hypothesis that APP codon 717 mutations, which lie within the transmembrane domain and beyond Abeta, increase Abeta release by altering APP internalization. This hypothesis will be specifically tested in the final specific aim. This investigation represents a detailed study of the APP internalization pathway, which we believe is highly relevant to Abeta production. Results from these studies should provide significant insights into the relationship between APP internalization, APP proteolysis, Abeta release, and familial AD mutations.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG012376-02
Application #
2053949
Study Section
Special Emphasis Panel (ZRG1-NLS-1 (01))
Project Start
1994-09-01
Project End
1996-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Eggert, Simone; Midthune, Brea; Cottrell, Barbara et al. (2009) Induced dimerization of the amyloid precursor protein leads to decreased amyloid-beta protein production. J Biol Chem 284:28943-52
Kummer, Markus P; Maruyama, Hiroko; Huelsmann, Claudia et al. (2009) Formation of Pmel17 amyloid is regulated by juxtamembrane metalloproteinase cleavage, and the resulting C-terminal fragment is a substrate for gamma-secretase. J Biol Chem 284:2296-306
Thinakaran, Gopal; Koo, Edward H (2008) Amyloid precursor protein trafficking, processing, and function. J Biol Chem 283:29615-9
Calabrese, Barbara; Shaked, Gideon M; Tabarean, Iustin V et al. (2007) Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-beta protein. Mol Cell Neurosci 35:183-93
Yoon, Il-Sang; Chen, Eunice; Busse, Tracy et al. (2007) Low-density lipoprotein receptor-related protein promotes amyloid precursor protein trafficking to lipid rafts in the endocytic pathway. FASEB J 21:2742-52
Lleo, Alberto; Waldron, Elaine; von Arnim, Christine A F et al. (2005) Low density lipoprotein receptor-related protein (LRP) interacts with presenilin 1 and is a competitive substrate of the amyloid precursor protein (APP) for gamma-secretase. J Biol Chem 280:27303-9
Yoon, Il-Sang; Pietrzik, Claus U; Kang, David E et al. (2005) Sequences from the low density lipoprotein receptor-related protein (LRP) cytoplasmic domain enhance amyloid beta protein production via the beta-secretase pathway without altering amyloid precursor protein/LRP nuclear signaling. J Biol Chem 280:20140-7
Pietrzik, Claus U; Yoon, Il-Sang; Jaeger, Sebastian et al. (2004) FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J Neurosci 24:4259-65
Pietrzik, Claus U; Busse, Tracy; Merriam, David E et al. (2002) The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing. EMBO J 21:5691-700
Koo, Edward H (2002) The beta-amyloid precursor protein (APP) and Alzheimer's disease: does the tail wag the dog? Traffic 3:763-70

Showing the most recent 10 out of 27 publications